James Hartley. “Aberrant Splicing Factor SF3A2 As a Prognostic Biomarker and Therapeutic Target in Colorectal Cancer: Interplay With Immune Infiltration and Natural Product Intervention”. International Journal of Medical Science and Dental Health 12, no. 09 (September 17, 2026): 176–181. Accessed September 18, 2026. https://www.ijmsdh.org/index.php/ijmsdh/article/view/743.